Supplies of the updated COVID-19 vaccine, designed to combat the XBB.1.5 strain and other similar subvariants, are still limited more than a month after approval, causing frustration among those seeking immunization appointments. Demand for the vaccine is steady but not overwhelming, and the supply constraint may be due to a fragmented distribution system. Pharmacies and doctor's offices have experienced hiccups and delays in receiving their orders, leading to a less predictable and consistent delivery of doses. People are advised to check various sources, including CVS, Walgreens, Hannaford pharmacies, and doctor's offices, for vaccine availability.
Some Americans are still struggling to find appointments for the latest version of the COVID-19 vaccine, with reports of upfront payments ranging from $150 to $200. The U.S. government has shifted responsibility for distribution, administration, and payment coverage to private companies, including vaccine makers, pharmacies, and insurance plans. Despite the rollout of millions of doses, individuals are facing difficulties in securing appointments, experiencing canceled appointments, and encountering payment refusals. Health insurance plans are required to cover the shots at no cost, but some people are being told that the new shots are not covered by their plan at certain locations. Independent pharmacists are also facing challenges as they now have to pay for the shots themselves.
